- ULURU is expected to launch Altrazeal in 10 countries in the Q2. We believe this will generate revenue of approximately $400k, up 4x from the Q1.
- We are expecting Altrazeal to launch in another 30 countries in the Q3 and Q4, generating revenue of approximately $1.2 million.
- Operating burn in the Q1 was only $160k. We believe the company is rapidly approaching cash flow positive operations.
- ULURU has undertaken several initiatives to improve the balance sheet, which now shows over $1.0 million in cash and $3.1 million in positive shareholder equity.
- Given the improvements in the balance sheet and the expected ramp in revenues over the next few quarters, we believe the shares are headed significantly higher by year end.